Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 100 of 145 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/10/19
End: 10/31/19
Due: 10/31/20
Phase: N/A
Priority: Normal
Start: 01/13/23
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 09/10/18
End: 04/30/19
Due: 04/30/20
Phase: N/A
Priority: Normal
Start: 12/15/21
End: 01/15/23
Due: 01/15/24
Phase: N/A
Priority: Normal
Start: 10/01/21
End: 10/01/23
Due: 10/01/24
Phase: N/A
Priority: Normal
Start: 06/28/22
End: 06/28/23
Due: 06/28/24
Phase: N/A
Priority: Normal
Start: 12/02/20
End: 12/15/23
Due: 12/15/24
Phase: N/A
Priority: Normal
Start: 06/05/21
End: 06/01/23
Due: 06/01/24
Phase: N/A
Priority: Normal
Start: 10/31/21
End: 10/31/23
Due: 10/31/24
Phase: N/A
Priority: Normal
Start: 01/31/20
End: 06/30/22
Due: 06/30/23
Phase: N/A
Priority: Normal
Start: 04/13/21
End: 12/30/28
Due: 12/30/29
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 08/31/13
Due: 08/31/14
Phase: N/A
Priority: Normal
Start: 11/08/22
End: 11/30/24
Due: 11/30/25
Phase: N/A
Priority: Normal
Start: 08/12/24
End: 11/21/26
Due: 11/21/27
Phase: N/A
Priority: Normal
Start: 10/10/18
End: 12/30/22
Due: 12/30/23
Phase: N/A
Priority: Normal
Start: 05/01/22
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 11/16/21
End: 11/28/21
Due: 11/28/22
Phase: N/A
Priority: Normal
Start: 08/07/18
End: 10/30/18
Due: 10/30/19
A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer
Phase: N/A
Priority: Normal
Start: 11/30/21
End: 05/31/24
Due: 05/31/25
Phase: N/A
Priority: Normal
Start: 04/02/18
End: 12/30/20
Due: 12/30/21
Phase: N/A
Priority: Normal
Start: 01/14/20
End: 06/03/21
Due: 06/03/22
Phase: N/A
Priority: Normal
Start: 10/30/17
End: 02/15/19
Due: 02/15/20
Phase: N/A
Priority: Normal
Start: 04/27/22
End: 10/01/23
Due: 10/01/24
Phase: N/A
Priority: Normal
Start: 10/20/21
End: 12/01/21
Due: 12/01/22
Phase: N/A
Priority: Normal
Start: 09/20/22
End: 03/20/25
Due: 03/20/26